mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-16 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
7e-15 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-13 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
4e-13 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
9e-13 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
1e-12 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-12 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-11 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
5e-11 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |